英文别名 |
5-[[(1S)-1-(6-Chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl]amino]-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile;5-[1-(6-Chloro-2-oxo-1H-quinolin-3-yl)ethylamino]-1-methyl-6-oxopyridine-2-carbonitrile;Olutasidenib;AKOS040742332;AKOS040742332;GTPL10319;GTPL10319;SCHEMBL17603134;SCHEMBL17603134;5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile;5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile;UNII-0T4IMT8S5Z;UNII-0T4IMT8S5Z;olutasidenibum;olutasidenibum;FT-2102;FT-2102;1887014-12-1;1887014-12-1;Olutasidenib (FT-2102)?;Olutasidenib (FT-2102)?;DA-56434;DA-56434;5-{[(1S)-1-(6-chloro-2-oxo-1H-quinolin-3-yl)ethyl]amino}-1-methyl-6-oxopyridine-2-carbonitrile;5-{[(1S)-1-(6-chloro-2-oxo-1H-quinolin-3-yl)ethyl]amino}-1-methyl-6-oxopyridine-2-carbonitrile;MS-25542;MS-25542;EX-A4523;EX-A4523;example 26 (US9834539B2);example 26 (US9834539B2);5-(((1S)-1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile;5-(((1S)-1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile;BDBM50506474;BDBM50506474;CS-0080183;CS-0080183;D12483;D12483;NSC818621;NSC818621;5-{[(1S)-1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl]amino}-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile;5-{[(1S)-1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl]amino}-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile;Olutasidenib [USAN];Olutasidenib [USAN];NEQYWYXGTJDAKR-JTQLQIEISA-N;NEQYWYXGTJDAKR-JTQLQIEISA-N;FT 2102;FT 2102;example 26 [US9834539B2];example 26 [US9834539B2];0T4IMT8S5Z;0T4IMT8S5Z;PWV;PWV;Rezlidhia (TN);Rezlidhia (TN);s8949;s8949;2-Pyridinecarbonitrile, 5-(((1S)-1-(6-chloro-1,2-dihydro-2-oxo-3-quinolinyl)ethyl)amino)-1,6-dihydro-1-methyl-6-oxo-;2-Pyridinecarbonitrile, 5-(((1S)-1-(6-chloro-1,2-dihydro-2-oxo-3-quinolinyl)ethyl)amino)-1,6-dihydro-1-methyl-6-oxo-;Olutasidenib (FT-2102);Olutasidenib (FT-2102);OLUTASIDENIB [WHO-DD];OLUTASIDENIB [WHO-DD];(S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile;(S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile;HY-114226;HY-114226;AC-36556;AC-36556;Olutasidenib (USAN/INN);Olutasidenib (USAN/INN);5-[[(1S)-1-(6-chloro-2-oxo-1H-quinolin-3-yl)ethyl]amino]-1-methyl-6-oxopyridine-2-carbonitrile;OLUTASIDENIB [INN];5-[[(1S)-1-(6-chloro-2-oxo-1H-quinolin-3-yl)ethyl]amino]-1-methyl-6-oxopyridine-2-carbonitrile;FT2102;OLUTASIDENIB [INN];IDH1-R132 Inhibitor FT-2102;FT2102;NSC-818621;IDH1-R132 Inhibitor FT-2102;D87221;NSC-818621;Rezlidhia;D87221;CHEMBL4297610;Rezlidhia;CHEMBL4297610 |